Anaesthesia and Wegovy: what your surgical team needs to know

Step 1: Tell your surgical team as soon as your procedure is planned

The moment a procedure is booked, disclose your Wegovy use to everyone involved: your GP, the surgeon's pre-assessment nurse and (critically) the anaesthetist at your pre-operative assessment. This is not optional or embarrassing. Anaesthetists need a complete drug history, and GLP-1 receptor agonists are now specifically flagged in pre-operative checks because of their effect on the stomach.

Wegovy works partly by slowing gastric emptying. Under normal circumstances that contributes to feeling full for longer. In a surgical context it creates a different picture: the stomach may retain contents well beyond the window that standard fasting protocols assume. Even a patient who has fasted from midnight can present with a fuller stomach than expected, raising the risk of aspiration, stomach contents entering the airway during induction of anaesthesia. The semaglutide and anaesthesia guidance page covers the pharmacological detail; the practical step here is simply to speak up early.

Quick checking habit: look at your Wegovy pen's batch number and the strength you are currently on before your pre-assessment appointment. Your anaesthetist will want to know your dose and when you last injected.

Step 2: Follow your surgical team's advice on whether to pause treatment

Some surgical teams and anaesthetic departments ask patients to hold their GLP-1 injection for one week before an elective procedure. Others, for shorter or lower-risk procedures, may take a different view. There is no single universal protocol in the UK yet, and decisions are made case by case based on the type of anaesthesia, the urgency of surgery and your individual clinical picture.

NHS England advises patients to tell their healthcare team, including the anaesthetist, that they are taking a GLP-1 medicine before any surgical procedure, this is the foundation that every other decision builds on. The Wegovy anaesthesia guidelines page goes deeper into the emerging professional-body guidance. What is clear is that stopping without a conversation is not the right move either: your prescriber needs to be part of that plan, because pausing and restarting a titrated medicine has its own clinical implications.

If your surgery is urgent or an emergency, the anaesthetic team will manage the risk through technique, rapid sequence induction is one established approach. The situation is manageable; it just needs to be declared.

Step 3: Restarting Wegovy after your procedure

Recovery from surgery often involves a period of reduced oral intake, IV fluids and significant GI disruption. Restarting Wegovy too soon after a procedure (particularly an abdominal one) can compound nausea, slow recovery of normal eating and, in some cases, interact with post-operative pain management. Your prescriber and surgical team should agree a restart point before you leave hospital, not afterwards.

The common side-effect profile of semaglutide is predominantly gastrointestinal: nausea, vomiting, constipation and reflux are the most frequently reported effects at the start of treatment or after a dose increase. Post-operative gut function is already disrupted, so layering a GLP-1 restart on top of that needs careful timing. Do not resume your injection on the day you get home simply because a week has passed.

You can report any unexpected effects after restarting via the MHRA Yellow Card scheme, which exists precisely for these post-market safety observations. If you are managing longer-term weight loss alongside other conditions, the Wegovy and MS page illustrates how comorbidities shape the clinical conversation, the same principle applies to surgical recovery.

What this means if you are considering starting Wegovy before planned surgery

If surgery is already scheduled within the next few weeks, starting a new GLP-1 medicine right now is worth a direct conversation with your prescriber before you proceed. Timing matters: starting Wegovy, allowing the gastric-emptying effect to establish and then having a procedure in the same short window is a scenario your anaesthetist would want flagged at the outset.

If you are exploring treatment options and surgery is not imminent, the clinical picture is straightforward: Wegovy is a licensed weight-management medicine in the UK for adults with a BMI of 30 or above, or 27 and above with a weight-related health condition, and your suitability is assessed by a prescriber who looks at your full health history. The weight-loss treatment overview gives a useful starting point for understanding the options. On cost context, the Wegovy cost guide sets out what private treatment typically involves, including what a legitimate price covers. For a prescription medicine, the relevant question is not which price is lowest but whether the clinical oversight is robust enough to catch exactly these kinds of interactions before they become a problem.

At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, a real clinician reads your answers, not software. Our clinical team, led by our clinical director, is available to answer questions about your specific circumstances. If you are ready to talk through your options, starting a free consultation is the right first step.